hMPV causes mild flu-like symptoms. However, it can lead to severe respiratory issues like pneumonia or bronchitis in infants, older adults, and those with weak immune systems.

hMPV, from the pneumoviridae family, infects respiratory tract cells, causing inflammation and symptoms like cough, fever, sore throat, and breathing difficulties.

hMPV spreads slowly and is less severe than COVID-19. It resembles RSV and COVID-19 but is not highly contagious and lacks pandemic-causing potential.

hMPV spreads via droplets from coughing, sneezing, or talking. It can also spread by touching contaminated surfaces and then touching your face. Practice hygiene to lower the risk

hMPV symptoms range from cough, runny nose, and fever to severe issues like pneumonia. Vulnerable groups may face fatigue, wheezing, or breathing difficulties.

Infants, elderly adults, and those with weakened immune systems or chronic conditions like asthma, diabetes, or kidney disease are at higher risk of severe hMPV complications.

Healthy individuals recover in 1-2 weeks. Vulnerable groups may take longer or need medical care. Complications like secondary infections can extend recovery time.

Prevent hMPV with hygiene: wash hands, avoid close contact with sick individuals, wear masks in public, and cover your mouth while sneezing or coughing.

No vaccine exists for hMPV. Treatment focuses on symptom relief with over-the-counter meds, hydration, rest, and supportive care like oxygen therapy if needed.

hMPV has no cure, but most recover with rest, hydration, and symptom management. Severe cases may require hospitalization or oxygen therapy for recovery.